[The role of tumor necrosis factor in pathogenesis and treatment of sarcoidosis].
A A
AA
Vizel'
M E
ME
Guryleva
E A
EA
Vizel'
G P
GP
Nasretdinova
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D000069285:Infliximab; D012507:Sarcoidosis / Q000188:drug therapy* / Q000378:metabolism*; D013792:Thalidomide / Q000494:pharmacology / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects* / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide; D000069285:Infliximab